Results 1 to 10 of about 6,597 (237)

The skin as a sentinel organ for neurodegeneration: An underrecognized target for dementia prevention. [PDF]

Intractable Rare Dis Res
Han Y, Zhou C, Wang P, Karako K, Song P.
europepmc   +1 more source

Prurigo pigmentosa in patient with diabetes on SGLT2 inhibitor. [PDF]

JAAD Case Rep
Khan T, Hirsch Y, McGivney R, Hoyer S.
europepmc   +1 more source

Rapid itch relief with the biologic agent nemolizumab in Atopic dermatitis and Prurigo nodularis: Promise, complexity and clinical implications. [PDF]

J Eur Acad Dermatol Venereol
Lukaschek K, Weisshaar E.
europepmc   +1 more source

Acute T-cell leukemia/lymphoma presenting with leukemia cutis mimicking prurigo nodularis. [PDF]

JAAD Case Rep
Elghannam M, Osto M, Strong J, Driscoll M.   +3 more
europepmc   +1 more source

Correction: Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. [PDF]

Dermatol Ther (Heidelb)
Yosipovitch G, Kim BS, Koo JY, Chen Z, Wiggins S, Zahn J, Sugerman P, Haddad EB, Cyr SL.   +8 more
europepmc   +1 more source

Upadacitinib for prurigo nodularis

JAAD Case Reports
Clara Muntaner-Virgili, MD, Carlos Moreno-Vilchez, MD, Clara Torrecilla-Vall-Llossera, MD, Ignasi Figueras-Nart, MD   +3 more
doaj   +1 more source

Impact of Chronic Nodular Prurigo on Quality of Life: A Systematic Review of the Literature. [PDF]

Dermatol Ther (Heidelb)
Herranz Pinto P, Pérez García B, Bonne Moreno V, Ortiz BN, De Paz Fernández HD, Lizán L.   +5 more
europepmc   +1 more source

Extensive skin ulcerations in an HIV-positive patient with AIDS: An atypical giant acquired perforating dermatosis-chronic prurigo spectrum presentation. [PDF]

JAAD Case Rep
Podoļanskis J, Nevidovska K, Mahmajeva O, Ābeltiņa K, Kalnbērza L.   +4 more
europepmc   +1 more source

Targeting IL-31RA with nemolizumab in prurigo nodularis: a systematic review, GRADE-assessed meta-analysis, and trial sequential analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Aldamen AO, Alqahtani R, Alqahtani R, Alanazi ZM, Almutairi LH, Alghatam AS, Alamari A, Altamimi I, Yadav R, Altamimi A.   +9 more
europepmc   +1 more source

Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Mercader P, Santos Alarcón S, Dominguez Liron N, Bernabeu A, Rodriguez Serna M, Fernandez-Crehuet P, Silvestre JF.   +7 more
europepmc   +1 more source